youtube_live
Q3 2026 earnings • released • EPS beat +16.09% • Revenue beat +2.79%
See resultschevron_right
PACB:NASDAQ
Pacific Biosciences of California Inc
$2.26
arrow_downward
-7.20%(-0.17) 1D
$2.25
arrow_downward
-0.14% (-0.0032)bedtimeAfter hours
Closed: Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PACB...
Open
$2.43
High
$2.54
Low
$2.24
Mkt. cap
700.92M
Avg. vol.
19.01M
Volume
9.56M
52-wk high
$3.44
52-wk low
$1.07
EPS
-$0.43
Beta
2.21
Shares outstanding
310.83M
No. of employees
485
Open
$2.43
High
$2.54
Low
$2.24
Mkt. cap
700.92M
Avg. vol.
19.01M
Volume
9.56M
52-wk high
$3.44
52-wk low
$1.07
EPS
-$0.43
Beta
2.21
Shares outstanding
310.83M
No. of employees
485
News stories
From web sources and news partners
TradingView
·
1 day ago
Key facts: PACB Q3 Revenue Rises 6%; Barclays and Piper Sandler Raise Price Targets
Seeking Alpha
·
1 day ago
Pacific Biosciences Q3: Another Revenue Guidance Cut
Yahoo Finance
·
2 days ago
Pacific Biosciences of California (PACB) Reports Q3 Loss, Beats Revenue Estimates
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees485
Founded2004
HeadquartersMenlo Park, California, United States
SectorHealth Care
Industry-
Websitepacb.com